- Home
- BCLI vs SDOT Comparison
BCLI vs SDOT Comparison
Compare BCLI & SDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- SDOT
- Stock Information
- Founded
- BCLI 2000
- SDOT 2014
- Country
- BCLI United States
- SDOT United States
- Employees
- BCLI N/A
- SDOT N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- SDOT Restaurants
- Sector
- BCLI Health Care
- SDOT Consumer Discretionary
- Exchange
- BCLI Nasdaq
- SDOT Nasdaq
- Market Cap
- BCLI 7.7M
- SDOT 8.0M
- IPO Year
- BCLI N/A
- SDOT 2020
- Fundamental
- Price
- BCLI $1.22
- SDOT $1.19
- Analyst Decision
- BCLI Strong Buy
- SDOT
- Analyst Count
- BCLI 1
- SDOT 0
- Target Price
- BCLI $30.00
- SDOT N/A
- AVG Volume (30 Days)
- BCLI 3.4M
- SDOT 76.2K
- Earning Date
- BCLI 05-15-2025
- SDOT 05-14-2025
- Dividend Yield
- BCLI N/A
- SDOT N/A
- EPS Growth
- BCLI N/A
- SDOT N/A
- EPS
- BCLI N/A
- SDOT 1.07
- Revenue
- BCLI N/A
- SDOT $726,598,000.00
- Revenue This Year
- BCLI N/A
- SDOT $12.76
- Revenue Next Year
- BCLI N/A
- SDOT $5.54
- P/E Ratio
- BCLI N/A
- SDOT $0.98
- Revenue Growth
- BCLI N/A
- SDOT 18.91
- 52 Week Low
- BCLI $0.72
- SDOT $1.12
- 52 Week High
- BCLI $8.09
- SDOT $7.00
- Technical
- Relative Strength Index (RSI)
- BCLI 55.90
- SDOT 33.39
- Support Level
- BCLI $1.05
- SDOT $1.16
- Resistance Level
- BCLI $1.18
- SDOT $1.25
- Average True Range (ATR)
- BCLI 0.14
- SDOT 0.09
- MACD
- BCLI 0.00
- SDOT 0.03
- Stochastic Oscillator
- BCLI 23.91
- SDOT 24.14
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.